COVID 19

The National Task force for COVID-19 constituted by ICMR recommends the use of hydroxychloroquine for prophylaxis of SARS-CoV -2 infection for high risk population.

Asymptomatic healthcare workers involved in the care of suspected or confirmed cases of COVID-19. Asymptomatic household contacts of laboratory confirmed cases

DOSE

Asymptomatic healthcare workers involved in the care of suspected or confirmed cases of COVID-19: 400 mg twice a day on Day 1, followed by 400 mg once weekly for next 7 weeks : to be taken with meals.

Asymptomatic household contacts of laboratory confirmed cases: 400 mg twice day on Day 1, followed by 400 mg once weekly for next 3 weeks, to be taken with meals.

Exclusion/contraindication

Drug is not recommended for prophylaxis in children under 15 years of age.

Drug is contraindicated in persons with retinopathy, hypersensitivity to HCQS or 4-aminoquinoline compounds

Hydroxychloroquine prophylaxis is to be taken ONLY as per prescription of a physician and baseline QTc interval should be calculated for all persons prior to administering the drug

Table of contents Ministry of Health &
Family Welfare Kerala Data : By C-DIT Situation Report : WHO Corona About outbreak Virus Morphology Transmission Pathophysiology Clinical Features Red flag signs Treatment Vaccines Definition of case Classification of contacts Classification of risk Clinical Categorization Treatment Guidelines UIP Guidelines Advisory for Pregnancy Quarantine & Testing IEC materials Drug prophylaxis FAQs Government Orders

Use of masks in the community

PPE Guidelines

Donning of PPE

Coronavirus Disease 2019 - COVID 19

Drug prophylaxis

DOSE

Exclusion/contraindication